动脉脉搏波传导速度与血尿酸的相关性研究
|
摘要
目的:探讨颈股动脉脉搏波传导速度(carotid-femoral pulse wavevelocity,cf-PWV)与血尿酸及肱动脉血流介导的内皮依赖性舒张功能(flow-mediated dilatation,FMD)的关系。
方法:收集已接受冠脉造影者173例,其中冠心病者113例,非冠心病者60例。采用PP-1000动脉弹性检测仪测定cf-PWV,静脉抽血查清晨空腹血清尿酸浓度,采用高分辨率超声检测FMD。
结果:1.冠心病者cf-PWV及血尿酸浓度高于非冠心病者(11.00±2.74比8.95±1.50;392.64±92.34比325.29±97.27;均P＜0.01),而FMD低于后者(7.50±2.26比10.03±1.97;P＜0.01)。2.在所有受试者中,单因素直线相关分析显示cf-PWV与血尿酸显著正相关(r=0.636,P＜0.001),与FMD显著负相关(r=-0.668,P＜0.001);以cf-PWV为因变量,年龄(Age)、性别、体重指数(BMI)、高血压(HBP)、糖尿病(DM)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)、甘油三酯(TG)、血尿酸及FMD为自变量行多元逐步回归分析显示,年龄、高血压、糖尿病、LDL-C、TG及血尿酸与cf-PWV分别呈独立正相关关系,FMD与cf-PWV呈独立负相关关系。3.在所有受试者中,单因素直线相关分析发现血尿酸与FMD呈显著负相关(r=-0.608,P＜0.001);以FMD为因变量,年龄、性别、BMI、高血压、糖尿病、LDL-C、HDL-C、TG及血尿酸为自变量的多元逐步回归分析中显示,年龄、高血压、糖尿病、LDL-C及血尿酸与FMD呈独立负相关关系。
结论:1.冠心病患者的cf-PWV显著高于非冠心病者,cf-PWV对冠心病可能有一定的辅助诊断价值。2.cf-PWV与血尿酸水平呈正相关关系,血尿酸可能是动脉硬化的独立危险因素。3.cf-PWV与FMD、FMD与血尿酸分别呈显著负相关,血尿酸可能通过损伤血管内皮功能促使动脉硬化的发生和发展。
Objective:To investigate the relationship between carotid-femoral pulse wave velocity(cf-PWV)、the serum uric acid and flow-mediated dilatation(FMD)of brachial artery.
Methods:Carotid-femoral pulse wave velocity(cf-PWV)was measured using PP-1000 automated analyzer.Fast serum uric acid(SUA) was measured in the morning.Flow-mediated dilation(FMD)in the brachial artery was measured using high resolution ultralsound assessment of the brachial artery diameter.
Results:113 patients with CHD and 60 non-CHD were recruited in the study.Cf-PWV and SUA was higher in CHD as compared to the non-CHD group(11.00±2.74 vs 8.95±1.50,P＜0.01;392.64±92.34 vs 325.29±97.27;P＜0.01).FMD was lower in CHD as compared to the non-CHD group(7.50±2.26 vs 10.03±1.97;P＜0.01).Univariate analysis demonstrate that there was a significant relationship between SUA and cf-PWV、FMD(P＜0.01).In all recruited subjects,multivariate stepwise regression analysis demonstrated that SUA and FMD were significant and independent factors for cf-PWV and SUA was an independent factor for FMD.
Conclusions:Compared with patients without CHD,there were higher cf-PWV in patients with CHD.PWV might have some value for CHD diagnosis.Cf-PWV was positively correlated with SUA and SUA might be involved to the pathogenesis of arteriosclerosis.FMD was negatively correlated with SUA and PWV.Maybe the underline mechanism between SUA and arteriosclerosis is the vascular endothelial dysfunction.
方法:收集已接受冠脉造影者173例,其中冠心病者113例,非冠心病者60例。采用PP-1000动脉弹性检测仪测定cf-PWV,静脉抽血查清晨空腹血清尿酸浓度,采用高分辨率超声检测FMD。
结果:1.冠心病者cf-PWV及血尿酸浓度高于非冠心病者(11.00±2.74比8.95±1.50;392.64±92.34比325.29±97.27;均P＜0.01),而FMD低于后者(7.50±2.26比10.03±1.97;P＜0.01)。2.在所有受试者中,单因素直线相关分析显示cf-PWV与血尿酸显著正相关(r=0.636,P＜0.001),与FMD显著负相关(r=-0.668,P＜0.001);以cf-PWV为因变量,年龄(Age)、性别、体重指数(BMI)、高血压(HBP)、糖尿病(DM)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)、甘油三酯(TG)、血尿酸及FMD为自变量行多元逐步回归分析显示,年龄、高血压、糖尿病、LDL-C、TG及血尿酸与cf-PWV分别呈独立正相关关系,FMD与cf-PWV呈独立负相关关系。3.在所有受试者中,单因素直线相关分析发现血尿酸与FMD呈显著负相关(r=-0.608,P＜0.001);以FMD为因变量,年龄、性别、BMI、高血压、糖尿病、LDL-C、HDL-C、TG及血尿酸为自变量的多元逐步回归分析中显示,年龄、高血压、糖尿病、LDL-C及血尿酸与FMD呈独立负相关关系。
结论:1.冠心病患者的cf-PWV显著高于非冠心病者,cf-PWV对冠心病可能有一定的辅助诊断价值。2.cf-PWV与血尿酸水平呈正相关关系,血尿酸可能是动脉硬化的独立危险因素。3.cf-PWV与FMD、FMD与血尿酸分别呈显著负相关,血尿酸可能通过损伤血管内皮功能促使动脉硬化的发生和发展。
Objective:To investigate the relationship between carotid-femoral pulse wave velocity(cf-PWV)、the serum uric acid and flow-mediated dilatation(FMD)of brachial artery.
Methods:Carotid-femoral pulse wave velocity(cf-PWV)was measured using PP-1000 automated analyzer.Fast serum uric acid(SUA) was measured in the morning.Flow-mediated dilation(FMD)in the brachial artery was measured using high resolution ultralsound assessment of the brachial artery diameter.
Results:113 patients with CHD and 60 non-CHD were recruited in the study.Cf-PWV and SUA was higher in CHD as compared to the non-CHD group(11.00±2.74 vs 8.95±1.50,P＜0.01;392.64±92.34 vs 325.29±97.27;P＜0.01).FMD was lower in CHD as compared to the non-CHD group(7.50±2.26 vs 10.03±1.97;P＜0.01).Univariate analysis demonstrate that there was a significant relationship between SUA and cf-PWV、FMD(P＜0.01).In all recruited subjects,multivariate stepwise regression analysis demonstrated that SUA and FMD were significant and independent factors for cf-PWV and SUA was an independent factor for FMD.
Conclusions:Compared with patients without CHD,there were higher cf-PWV in patients with CHD.PWV might have some value for CHD diagnosis.Cf-PWV was positively correlated with SUA and SUA might be involved to the pathogenesis of arteriosclerosis.FMD was negatively correlated with SUA and PWV.Maybe the underline mechanism between SUA and arteriosclerosis is the vascular endothelial dysfunction.
引文
[1] Gertler MM, Gam SM, Levine SA, et al. Serum Uric acid in relation to age and physique in health and in coronary heart disease.Ann Intenr Med, 1951,34:1421-1431.
[2] Torun M, Yardim S, Simsek B, et al. Serum uric acid levels in cardiovascular diseases.J Clin Pharm Ther 23, 1998:25-29.
[3] Baker JF, Krishnan E, Chen L, et al. Serum uric acid and cardiovascular disease: recent developments, where do they leave us? Am J Med 118,2005:816-826.
[4] Wannamethee SG. Serum uric acid and risk of coronary heart disease, Curr Pharm Des 11, 2005:4125-4132.
[5] Bickel C, Rupprecht HJ, Blankenberg S, et al. Sderum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease[J]. Am J Cardiol 2002, 89(1): 12-17.
[6] Bengtsson C, Lapidus L, Stendahl C, et al. Hyperuricemia and risk of cardiovascular disease and overall death. A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden, Acta Med Scand 224 , 1988:549-555.
[7] CuDeton BF, Larson MG, Kannel WB, et al.Serum uric acid and risk for cardiovascular disease and death: the framingham heart study[J].Ann InternMed,1999,131:7-13.
[8] SutonTyrrell K,Mackey RH,Holubkov R,et al.Measurement variation of aorticpulsewave velocity in the elderly.Am J Hypertens ,2001; 14 (5Ptl):463-468.
[9] Liang YL, Teede H, Kotsopoulos D, et al. Noninvasive measurements of arterial structure and function:repeatability,Interrelationships and trial samplesize. Clin Sci, 1998, 95:669-679.
[10] Wilkinson IB, Fuchs SA, Jansen IM, et al.Reproducibility of pulse wave velocity and augmenttion index measured by pulse wave analysis.J hypertens , 1998:16:2079-2084.
[11] SiebenhoferA, KempC, SutonA, et al. The reproducibility of central aortic blood pressure measurements in healthy subjects using applanation tonometry and sphygmo cardiography. J HumHypertens, 1999(13):625-629.
[12] Laurent S, Katsahian S, Fassot C, et al. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke 2003, 34(12): 3-6.
[13] Boutouyrie P, Tropeano AI, Asmar R, et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients:a longitudinal study.Hypertension 2002, 39:1-5.
[14] Laurent S, Boutouyrie P, Asmar R, et al. Aortic stiffness is an indepen-dent predictor of all-cause and cardiovascular mortality inhypertensive patients.Hypertension 2001, 37:36-41.
[15] Cruickshank K, RisteL, Anderson SG, et al. Aortic pulse-wave velocity and its relationshipto mortality in diabetes and glucose intolerance:an integrated index of vascular function?Circulation 2002, 106:85-90.
[16] ShojiT, EmotoM, ShinoharaK, et al. Diabetesmellitus,aortic stiffness,and cardiovascular mortality inend-stage renal disease.J Am Soc Nephrol 2001;12:2117-24.
[17] Blacher J, Guerin AP, Pannier B, et al. Impact of aortic stiffness on survival in end-stage renal disease.Circulation 1999; 99:2434-9.
[18] Shokawa T, Imazu M, Yamamoto H, et al. Pulse wave velocity predicts cardiovascular mortality:findings from the Hawaii-LosAngeles-Hiroshima study. Circ J 2005; 69:259-64.
[19] Hansen TW, Staessen JA, Torp-Pedersen C, et al. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population.Circulation 2006; 113:664-70.
[20] Meaume S,Benetos A,Henry OF,et al.Aortic pulse wave velocity predicts cardiovascular mortality in subjects>70 years of age.Arterioscler Thromb Vasc Biol,2001;21:2046-50.
[21] Sutton-Tyrrell K,Najjar SS,Boudreau RM,et al.HealthABC Study.Elevated aortic pulse wave velocity,a markerof arterial stiffness,predicts cardiovascular events in well-functioning older adults.Circulation 2005;111:3384-90.
[22] Mattace-Raso F,vander Cammen T,Hofman A,et al.Arterial stiffness and risk of coronary heart disease and stroke:the Rotterdam Study.Circulation 2006;113:657-63.
[23] Pierre B, Boutouyrie A, Anne I, et al.Aortic stiffness is an independent predictor of primary coronary event in hypertensive patients. Hypertension 2002(1):10-15.
[24]Asmar R and Benetos A.Assessment of arterial distensibility by automatic pulse wave velocity measurement.Validation and Clinical application studies,[J].Hypertension,1995(26):485-490.
[25]Shin-ichiro,Katusta,Masamitsu,et al.Comparison of pulse-wave velocity in differentaortic regions in relation to the extent and severity of atherosclerosis between young and older Kurosawa and Kusanagi Hyper-cholesterolemic (KHC)rabbits.Clinical Science2000(99):393-404.
[26]Van Polele NM,Mattace-Raso FUS,Vliegenthart R,et al.Aortic stiffness is associated with atherosclerosis of the coronary arteries in older adults:The Rotterdam Study.J Hypertens.2006,24(12):2371-2376.
[27]Yasue H,Mat suyama K,Mat suyama K,et al.Responses of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment:Possible role of early coronary atherosclerosis Circulation,1990,81(2):482-490.
[28]Celermajer DS,Sorensen KE,Gooch VM,et al.Noninvasive detection Of endot belial dysf- unction in children and adult s at risk of at hero sclero sis[J].Lancet,1992,340:1111-1115.
[29]Schachinger V,Briten MB,Zeiher AM,et al.Prognostic impact of coronary vasodilatordsy function on adverse long-term outcome of coronary heart diaeses.Circulation,2000,(101):1899-1906.
[30]Neuntuefl T,Heber S,KatZenschlager R,et al.Late Prognostic value of flow-mediated dilatinon in the brachial artery of Patients with chest Pain.Am J Cardio,2000:July 15;86(2):207-210.
[31]Schroeder S,Enderleh MD,Ossen R.et al.Noninvasive determination of endothlim- mediated vasodilation as a screening test for coronary artery disease:polot study to assess the predictive value in comparison with angina pectoris,exercise electrocardiography and myocardial perfusion imaging.Am Heart J,1999;138:731-739.
[32]王宏宇,胡大一.血管内皮功能检测的临床应用.中国医刊,2003,38(3):57-59.
[33]Butler R,Morris AD,Belch J,et al.Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension,Hypertension 352000:746-751.
[34]Baldus S,Koster R,Chumley P,et al.Oxypurinol improves coronary and peripheral endothelial function in patients with coronary artery disease,Free Radic Biol Med 39,2005:1184-1190.
[35]Farquharson CA.,Butler R,Hill A,et al.Allopurinol improves endothelial dysfunction in chronic heart failure,Circulation 106,2002:221-226.
[36]Cohn JN.Arteries,myocardium,blood pressure and cardiovascular risk:towards a revised definition of hypertension[J].J Hypertens,1998,16(12Pt2):2117-2124.
[37]Erdogan H,Gullu M,Caliskan M,et al.Relationship of serum uric acid to measures of endothelial function and atherosclerosis in healthy adults,Int J Clin Pract 59,2005:1276-1282.
[38]Ishizaka Y,Ishizaka EI,Toda M,et al.Higher serum uric acid is associated with increased arterial stiffness in Japanese individuals,Atherosclerosis 192,2007:131-137.
[39]龚兰生,许玉韵,张维忠,等.中国血管病变早期检测技术应用指南(第一次报告).中国民康医学杂志.2006,(18):323-331.
[40]Baker JF,Krishnan E,SchumacherHR,et al.Serum uric acid and cardiovascular- disease:Recent developments,and where do they leave us[J]Am JMed,2005,118(8):816-826.
[41]Fang J and Alderman MH.Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study,1971-1992.National Health and Nutrition Examination Survey[J].JAMA,2000,283(18):2404-2410.
[42]Niskanen LK,Laaksonen DE,Nyyssonen K,et a.l Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men:a prospective cohort study[J].Arch InternMed,2004,164(14):1546-1551.
[43]Suama C,Dean RT,May J,et al.Human atherosclerotic plaque contains both oxidized lipids an ascorbate[J].Arteriolcler Thromb Vasc Biod,1995,15:1616.
[44]Kobayashi K,Akishita M,Yu W,et at.Interrelationship betweennoninvasive measurements of atherosclerosis:flow-mediated dilation of brachial artery,carotid intima-media thickness and pulse wave velocity.Atherosclerosis,2004,173:13-18.
[45]LIU Dong-hong,WANG Yan,LIAO Xin-xue,et al.Increased brachial-ankle pulse wave velocity is associated with impaired endothelial function in patients with coronary artery disease.Chin Med J 2006;119(22):1866-1870
[46]McLeod AL,Newby DE,Northridge DB,et al.Influence of differential vascular remodeling on the coronary vasomotor response.Cardiovasc Res,2003,59:520-6.
[47]Jambrik Z,Venneri L,VargaA,et al.Peripheral vascular endothelial function testing for the diagnosis of coronary artery disease.Am HeartJ,2004,148(4):684-689.
[48]Cohn JN.Arteries,myocardium,blood pressure and cardiovascular risk:towards a revised definition of hypertension.J Hypertens,1998,16(12 Pt 2):2117-2124.
[49]张维忠.动脉弹性功能临床研究的现状和意义.中华心血管病杂志,2003,31(4):243-244.
[50]Mcleod AL,Newby DE,Northridge DB,et al.Influence of differentialvascular remodeling on coronary vasomotor response.CardiovascularRes,2003,59(2):520-526.
[51]Schwarzacher SP,Uren NG,Ward MR,et al.Determinants of coronary remodeling in transplant coronary disease:a simultaneous intravascular ultrasound and Doppler flow study.Circulation,2000,101(12):1384-1389.
[52]Erdogan D,Gullu H,Caliskan M,et al.Coronary flow reserve and coronary microvascular functionsare strongly related to serum uric acid concentrations in healthy adults[J].Coron Artery Dis,2006,17(1):7-14.
[53]Becker BE Towards the physiological function of uric acid.Free Radic BiolMed,1993,14:615-631.
[54]ErdoganD,GulluH,CaliskanM,et al.Relationship of serum uric acid to measures of endothelial function and atherosclerosis in healthy adults[J].International JournalofClinicalPractice,2005,59(11):1276-1282.
[55]FrohlichM,ImhofA,BergG,eta.l Association betweenC-reactive protein and features of themetabolic syndrome:a population-based study[J].DiabetesCare,2000,23:1835-1839
[56]ShiY,Evans JE,Rock KL.Molecular identification of a danger signal that alerts the immune system todying cells.Nature,2003,425:516-521.
[57]Rao GN,Corson MA,Berk BC,et al.Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression,J Biol Chem 266,1991:8604-8608.
[58]Hare J and JohnsonR.Uric acid predicts clinical outcomes in heart failure.Insights regarding the role of xanthine oxidase and uric acid in disease pathophysiology,Circulation 107,2003:1951-1953.
[59]Johnson DH,Kang D,Feig S,et al.Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?Hypertension 412003:1183-1190.
[1] Baker JF, Krishnan E, Chen L,et al. Serum uric acid and cardiovascular disease:recent developments, where do they leave us?, Am J Med 118,2005:816-826.
[2] Wannamethee SGSerum uric acid and risk of coronary heart disease, Curr Pharm Des 11 ,2005:4125-4132.
[3] YuJun-wen, LuJin-bo, ZhangXiao-jusn, et al.The analysis of 1320 elder's blood uric acid and blood-lipid,blood glucose,hypertension.Chinese Journal of Epidemiology ,2005,26:455-457.
[4] Fang Qi,You Kai,Lin Qi-sui,et al.The investigation of Chinese people's blood uric acid and the relationship between it and blood-lipid.Chinese Journal of Internal Midieine,1983,22:434-438.
[5] Fang Wei-gang,Huang Xiao-ming,wang Yu,etal.The analysis of hyperuriemia among 1,997 people's cases in Beijing area and the related faetors.Chinese Journal of Medieine,2006,86(25): 1764-1768.
[6] Zhang Xue shun,Yu Wen-guang,Yu Li-xia,et al.The epidemiology investigation of hyperuricemia and gout in Shandong province Haiyang city community's resident.Chinese Journal of General Praetitioners,2006,5(4):216-219.
[7] Shao Ji-hong,Mo Bao-qing,Yu Rong-bin, et al.The epidemiology Investigation of hyperuric- emia and gout in Nanjing city conmmunity's public.Chjnese Journal of Disease Control and Prevention,2003,7(4):305-308.
[8] OyamaC,Takallashi T,Oyamad,M,et al.Serum Uric acid as an Obesity-Related Indicator in early adolescence.Tohoku J ExP Med,2006,209(3):257-562.
[9] Yu Zhi-min,Zhang Li-song,YangLi-fang.The investigation and analysis of hyperuricemia in Guangzhou area public.Aeta nutrimenta Sinie, 2004,26(3):201-203.
[10] Mohamed FA,et al. On chronic Bright's disease and its essential symptoms.Lancet. 1879, 1:399-401.
[11] Haig A,et al. On uric acid and arterial tension. British Medical Journal. 1889 1:288-291.
[12]Masuo K,Kawaguchi H,Mikami H,et al.Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation.Hypertension.2003;42:474-480.
[13]Jossa F,Farinaro E,Panico S,et al.Serum uric acid and hypertension the Olivetti heart study Hum Hypertens,1994,8:667-681.
[14]Sundstrom J,Sullivan L D,Agostino R B,et al.Relation of serum uric acid to longitudinal blood pressure tracking and hypertension incidence.Hypertension,2005,45:28-33.
[15]Mazzali M,Hughes J,Kim YG,et al.Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism.Hypertension.2001,38:1101-1106.
[16]Mazzali M,Hughes J,Kim YG,et al.Elevated uric increases blood pressure in the rat by anovelcrystla independent mechanism.Hypertension,2001,38(5):1101-1106.
[17]朱宇,纪立农.2型糖尿病患者中高尿酸血症的研究.临床荟萃,2006,21(1):22-24.
[18]鹿斌,董雪红,杨叶虹,等.上海市中心城区成人2型糖尿病患者高尿酸血症患病率及其相关危险因素分析.中国临床医学,2006,13(2):243-245.
[19]Bo S,Cavallo-Perin RGentile L,et al.Hypouricemia and hyperuricemiain type 2diabetes:two different phenotypes.Eur J Clin Invest,2001,31:318-321.
[20]MatsuuraF,Yamhitas,NakamuraT,etal.Efect of visceral fat ccumulation on uric acid metabolism in male obesity subjects visceral fat obesity is linked more closely to over production of uric acid than subcutaneous fatuity.Metaboilsm,1998,47:929-933.
[21]Modan M,Halkin H,Karseik A,et al.Elevated serum uric acid-a fecet of hyperinsulinaemia.Diabetologia,1987,30:713-718.
[22]Matsuura F,Yamashita S,Nakamura T,et al.Effect of visceral fat accumulation on uric acid metabolism in male obese subjects:visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity. Metabolism,1998,47:929-933.
[23]Anker SD,Doehner W,Rauchhaus M,et al.Uric acid and survival in chronic heart failure:validation and application in metabolic,functional,andhemodynamicstaging.Circulation,2003,107(15):1991.
[24]孙丽英,牛秀波,李建博,等.2004年河北省沧州市1215例男性血尿酸、血脂水平分析及痛风发病率的相关调查[J].中国医学检验杂志,2005,6(2):135,157.
[25]余俊文,陆锦波,张小娟,等.1320名老年人血尿酸与血脂、血糖和血压的分析.中华流行病学杂志,2005,26(6):455-457.
[26]Alderman MH.Uric acid and cardiovascular risk.Currop in Phar-macol,2002,2(2):126-130.
[27]Ghei M,M ihaileseu M,Levinson D.Pathogenesis of hyperuricem ia:recent advances.Curr Rheumatol Rep,2002,4(3):270-274.
[28]Chu NF,Wang DJ,L iou SH,et al.Relationship between hyperuricmia and other cardiovascular disease risk factors among adult males in Taiwan.Eur J Ep idem iol,2000,16(1):13-17.
[29]Baker JF,Krishnan E,Chen L,et al.Serum uric acid and cardiovascular disease:recent developments,where do they leave us?,Am J Med 118,2005:816-826
[30]Wannamethee SG.Serum uric acid and risk of coronary heart disease,Curr Pharm Des 11(2005):4125-4132.
[31]CuIleton BF,Larson MG,Kannel WB,et al.Serum uric acid and risk for cardiovascular disease and death:the Framingham heart study.Ann InternMed,1999,131:7-13.
[32]Gertler MM,Gam SM,Levine SA.Serum Uric acid in relation to age and physique in health andin coronary heart disease.Ann Intenr Med,1951,34:1421-1431.
[33]Baker JF,Krishnan E,Chen L.et al.Serum uric acid and cardiovascular disease:Recent developments,and where do they leave us.Am JMed,2005,118(8):816-826.
[34]Niskanen LK,Laaksonen DE,Nyyssonen K,et a.l Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study.Arch InternMed, 2004, 164(14): 1546-1551.
[35] Karagiannis A,Mikhailidis DP,Tziomalos K,et al.Serum uric acid as an independent predictor of early death after acute stroke.Circ J, 2007, 71:1120-1127.
[36] Baker JF,Krishnan E,Chen L. SchumacherHR,et al.Serum uric acid and cardiovasculardisease: Recent developments, and where do they leave us. Am JMed,2005,118(8):816-826.
[37] Suarna C,Dean RT,May J,et al.Human atherosclerotiv piaque contains both oxidized lipids an ascorbate.Arteriolcler Thromb Vasc Biod, 1995,15:1616.
[38] Fang J,Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992.National Health and Nutrition Examination Survey. JAMA, 2000, 283(18): 2404-2410.
[39] Niskanen LK, Laaksonen DE,Nyyssonen K, et a.l Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study.Arch InternMed, 2004, 164(14): 1546-1551.
[40] Kawamoto R,Tomita H,Oka Y,etal.Relationship between serum uric acid concentration,metabolic syndrome and carotid atherosclerosis.Intern Med,2006,45:605-614.
[41] Maxwell SR,Thomason H, Sandier D, et al Antioxidant status in patients with uncomplicated insulin-dependent and noninsulin-dependent diabetes mellitus .Eur JClin Invest ,1997,27:484-490.
[42] Skinner KA,White CR, Patel R, et al Nitrosation of uric acid by peroxynitrite.Formation of avasoactive nitric oxide donor. J BiolChem, 1998,273:24491-24497.
[43] George J,CarrE,Davies J, eta.1High-Dose allopurinol improves endothelial function byprofoundly reducingvascularoxidative stress and not by lowering uric acid[J].Circulation,2006,114(23):2508-2516.
[44] FrohlichM, ImhofA,BergG, eta.I Association betweenC-reactive protein and features of themetabolic syndrome: a population-based study[J]. DiabetesCare, 2000,23:1835-1839.
[45]Shi Y,Evans JE,Rock KL.Molecular identification of a danger signal that alerts the immune system todying cells.Nature,2003,425:516-521.
[46]Ruggiero C,Cherubini A,Ble A,et a.l Uric acid and inflammatory markers.EurHeart J,2006,27(10):1174-1181.
[47]JohnsonRJ,KangDH,FeigD,etal Is there apathogenetic role for uric acid in hypertension and cardiovascularand renaldisease? Hypertension,2003,416:1183-1190.
[48]ErdoganD,GulluH,CaliskanM,eta.l Relationship of serum uric acid to measures of endothelial function and atherosclerosis in healthy adults.International JournalofClinicalPractice,2005,59(11):1276-1282.
[49]Erdogan D,Gullu H,Caliskan M,eta.l Coronary flow reserve and coronary microvascular functionsare strongly related to serum uric acid concentrations in healthy adults.Coron Artery Dis,2006,17(1):7-14.
[50]Hare J,JohnsonR.Uric acid predicts clinical outcomes in heart failure.Insights regarding the role of xanthine oxidase and uric acid in disease pathophysiology,Circulation 107(2003):1951-1953.
[51]Johnson,D.H.Kang,D.Feig,S.et al.Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?Hypertension 41(2003):1183-1190.
[52]邵继红,徐耀初,莫宝庆.高尿酸血症与痛风的分子流行病学研究进展.国外医学卫生学分册,2003,30(4):238-241.
[53]Mann DL,Mechanisms and models in heart failure:A combinational approach.Circulation,1999,100(9):999-1008.
[54]陈章强,洪浪,王洪,等.慢性心力衰竭患者血清尿酸水平的变化及其临床意义.江西医药,2006,41:480-481.
[55]Anker SD,Doehner W,Rauchhaus M,etal.Uric acid and survival in chronic heart failure:validation and application in metabolic,functional,andhemodynamicstaging.Circulation,2003,107:1991-1997.
[56]SingalPK,KhaperN,Palace V,et a.l The role of oxidative stress in the genesis ofheartdisease.CardiolRes,1998,40:426-432.
[57]NianM,Lee P,KhaoerN,et al.Inflammatory cytokines and postmyocardial infarction remodeling.Circ Res,2004,94(12):1543-1553.
[2] Torun M, Yardim S, Simsek B, et al. Serum uric acid levels in cardiovascular diseases.J Clin Pharm Ther 23, 1998:25-29.
[3] Baker JF, Krishnan E, Chen L, et al. Serum uric acid and cardiovascular disease: recent developments, where do they leave us? Am J Med 118,2005:816-826.
[4] Wannamethee SG. Serum uric acid and risk of coronary heart disease, Curr Pharm Des 11, 2005:4125-4132.
[5] Bickel C, Rupprecht HJ, Blankenberg S, et al. Sderum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease[J]. Am J Cardiol 2002, 89(1): 12-17.
[6] Bengtsson C, Lapidus L, Stendahl C, et al. Hyperuricemia and risk of cardiovascular disease and overall death. A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden, Acta Med Scand 224 , 1988:549-555.
[7] CuDeton BF, Larson MG, Kannel WB, et al.Serum uric acid and risk for cardiovascular disease and death: the framingham heart study[J].Ann InternMed,1999,131:7-13.
[8] SutonTyrrell K,Mackey RH,Holubkov R,et al.Measurement variation of aorticpulsewave velocity in the elderly.Am J Hypertens ,2001; 14 (5Ptl):463-468.
[9] Liang YL, Teede H, Kotsopoulos D, et al. Noninvasive measurements of arterial structure and function:repeatability,Interrelationships and trial samplesize. Clin Sci, 1998, 95:669-679.
[10] Wilkinson IB, Fuchs SA, Jansen IM, et al.Reproducibility of pulse wave velocity and augmenttion index measured by pulse wave analysis.J hypertens , 1998:16:2079-2084.
[11] SiebenhoferA, KempC, SutonA, et al. The reproducibility of central aortic blood pressure measurements in healthy subjects using applanation tonometry and sphygmo cardiography. J HumHypertens, 1999(13):625-629.
[12] Laurent S, Katsahian S, Fassot C, et al. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke 2003, 34(12): 3-6.
[13] Boutouyrie P, Tropeano AI, Asmar R, et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients:a longitudinal study.Hypertension 2002, 39:1-5.
[14] Laurent S, Boutouyrie P, Asmar R, et al. Aortic stiffness is an indepen-dent predictor of all-cause and cardiovascular mortality inhypertensive patients.Hypertension 2001, 37:36-41.
[15] Cruickshank K, RisteL, Anderson SG, et al. Aortic pulse-wave velocity and its relationshipto mortality in diabetes and glucose intolerance:an integrated index of vascular function?Circulation 2002, 106:85-90.
[16] ShojiT, EmotoM, ShinoharaK, et al. Diabetesmellitus,aortic stiffness,and cardiovascular mortality inend-stage renal disease.J Am Soc Nephrol 2001;12:2117-24.
[17] Blacher J, Guerin AP, Pannier B, et al. Impact of aortic stiffness on survival in end-stage renal disease.Circulation 1999; 99:2434-9.
[18] Shokawa T, Imazu M, Yamamoto H, et al. Pulse wave velocity predicts cardiovascular mortality:findings from the Hawaii-LosAngeles-Hiroshima study. Circ J 2005; 69:259-64.
[19] Hansen TW, Staessen JA, Torp-Pedersen C, et al. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population.Circulation 2006; 113:664-70.
[20] Meaume S,Benetos A,Henry OF,et al.Aortic pulse wave velocity predicts cardiovascular mortality in subjects>70 years of age.Arterioscler Thromb Vasc Biol,2001;21:2046-50.
[21] Sutton-Tyrrell K,Najjar SS,Boudreau RM,et al.HealthABC Study.Elevated aortic pulse wave velocity,a markerof arterial stiffness,predicts cardiovascular events in well-functioning older adults.Circulation 2005;111:3384-90.
[22] Mattace-Raso F,vander Cammen T,Hofman A,et al.Arterial stiffness and risk of coronary heart disease and stroke:the Rotterdam Study.Circulation 2006;113:657-63.
[23] Pierre B, Boutouyrie A, Anne I, et al.Aortic stiffness is an independent predictor of primary coronary event in hypertensive patients. Hypertension 2002(1):10-15.
[24]Asmar R and Benetos A.Assessment of arterial distensibility by automatic pulse wave velocity measurement.Validation and Clinical application studies,[J].Hypertension,1995(26):485-490.
[25]Shin-ichiro,Katusta,Masamitsu,et al.Comparison of pulse-wave velocity in differentaortic regions in relation to the extent and severity of atherosclerosis between young and older Kurosawa and Kusanagi Hyper-cholesterolemic (KHC)rabbits.Clinical Science2000(99):393-404.
[26]Van Polele NM,Mattace-Raso FUS,Vliegenthart R,et al.Aortic stiffness is associated with atherosclerosis of the coronary arteries in older adults:The Rotterdam Study.J Hypertens.2006,24(12):2371-2376.
[27]Yasue H,Mat suyama K,Mat suyama K,et al.Responses of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment:Possible role of early coronary atherosclerosis Circulation,1990,81(2):482-490.
[28]Celermajer DS,Sorensen KE,Gooch VM,et al.Noninvasive detection Of endot belial dysf- unction in children and adult s at risk of at hero sclero sis[J].Lancet,1992,340:1111-1115.
[29]Schachinger V,Briten MB,Zeiher AM,et al.Prognostic impact of coronary vasodilatordsy function on adverse long-term outcome of coronary heart diaeses.Circulation,2000,(101):1899-1906.
[30]Neuntuefl T,Heber S,KatZenschlager R,et al.Late Prognostic value of flow-mediated dilatinon in the brachial artery of Patients with chest Pain.Am J Cardio,2000:July 15;86(2):207-210.
[31]Schroeder S,Enderleh MD,Ossen R.et al.Noninvasive determination of endothlim- mediated vasodilation as a screening test for coronary artery disease:polot study to assess the predictive value in comparison with angina pectoris,exercise electrocardiography and myocardial perfusion imaging.Am Heart J,1999;138:731-739.
[32]王宏宇,胡大一.血管内皮功能检测的临床应用.中国医刊,2003,38(3):57-59.
[33]Butler R,Morris AD,Belch J,et al.Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension,Hypertension 352000:746-751.
[34]Baldus S,Koster R,Chumley P,et al.Oxypurinol improves coronary and peripheral endothelial function in patients with coronary artery disease,Free Radic Biol Med 39,2005:1184-1190.
[35]Farquharson CA.,Butler R,Hill A,et al.Allopurinol improves endothelial dysfunction in chronic heart failure,Circulation 106,2002:221-226.
[36]Cohn JN.Arteries,myocardium,blood pressure and cardiovascular risk:towards a revised definition of hypertension[J].J Hypertens,1998,16(12Pt2):2117-2124.
[37]Erdogan H,Gullu M,Caliskan M,et al.Relationship of serum uric acid to measures of endothelial function and atherosclerosis in healthy adults,Int J Clin Pract 59,2005:1276-1282.
[38]Ishizaka Y,Ishizaka EI,Toda M,et al.Higher serum uric acid is associated with increased arterial stiffness in Japanese individuals,Atherosclerosis 192,2007:131-137.
[39]龚兰生,许玉韵,张维忠,等.中国血管病变早期检测技术应用指南(第一次报告).中国民康医学杂志.2006,(18):323-331.
[40]Baker JF,Krishnan E,SchumacherHR,et al.Serum uric acid and cardiovascular- disease:Recent developments,and where do they leave us[J]Am JMed,2005,118(8):816-826.
[41]Fang J and Alderman MH.Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study,1971-1992.National Health and Nutrition Examination Survey[J].JAMA,2000,283(18):2404-2410.
[42]Niskanen LK,Laaksonen DE,Nyyssonen K,et a.l Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men:a prospective cohort study[J].Arch InternMed,2004,164(14):1546-1551.
[43]Suama C,Dean RT,May J,et al.Human atherosclerotic plaque contains both oxidized lipids an ascorbate[J].Arteriolcler Thromb Vasc Biod,1995,15:1616.
[44]Kobayashi K,Akishita M,Yu W,et at.Interrelationship betweennoninvasive measurements of atherosclerosis:flow-mediated dilation of brachial artery,carotid intima-media thickness and pulse wave velocity.Atherosclerosis,2004,173:13-18.
[45]LIU Dong-hong,WANG Yan,LIAO Xin-xue,et al.Increased brachial-ankle pulse wave velocity is associated with impaired endothelial function in patients with coronary artery disease.Chin Med J 2006;119(22):1866-1870
[46]McLeod AL,Newby DE,Northridge DB,et al.Influence of differential vascular remodeling on the coronary vasomotor response.Cardiovasc Res,2003,59:520-6.
[47]Jambrik Z,Venneri L,VargaA,et al.Peripheral vascular endothelial function testing for the diagnosis of coronary artery disease.Am HeartJ,2004,148(4):684-689.
[48]Cohn JN.Arteries,myocardium,blood pressure and cardiovascular risk:towards a revised definition of hypertension.J Hypertens,1998,16(12 Pt 2):2117-2124.
[49]张维忠.动脉弹性功能临床研究的现状和意义.中华心血管病杂志,2003,31(4):243-244.
[50]Mcleod AL,Newby DE,Northridge DB,et al.Influence of differentialvascular remodeling on coronary vasomotor response.CardiovascularRes,2003,59(2):520-526.
[51]Schwarzacher SP,Uren NG,Ward MR,et al.Determinants of coronary remodeling in transplant coronary disease:a simultaneous intravascular ultrasound and Doppler flow study.Circulation,2000,101(12):1384-1389.
[52]Erdogan D,Gullu H,Caliskan M,et al.Coronary flow reserve and coronary microvascular functionsare strongly related to serum uric acid concentrations in healthy adults[J].Coron Artery Dis,2006,17(1):7-14.
[53]Becker BE Towards the physiological function of uric acid.Free Radic BiolMed,1993,14:615-631.
[54]ErdoganD,GulluH,CaliskanM,et al.Relationship of serum uric acid to measures of endothelial function and atherosclerosis in healthy adults[J].International JournalofClinicalPractice,2005,59(11):1276-1282.
[55]FrohlichM,ImhofA,BergG,eta.l Association betweenC-reactive protein and features of themetabolic syndrome:a population-based study[J].DiabetesCare,2000,23:1835-1839
[56]ShiY,Evans JE,Rock KL.Molecular identification of a danger signal that alerts the immune system todying cells.Nature,2003,425:516-521.
[57]Rao GN,Corson MA,Berk BC,et al.Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression,J Biol Chem 266,1991:8604-8608.
[58]Hare J and JohnsonR.Uric acid predicts clinical outcomes in heart failure.Insights regarding the role of xanthine oxidase and uric acid in disease pathophysiology,Circulation 107,2003:1951-1953.
[59]Johnson DH,Kang D,Feig S,et al.Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?Hypertension 412003:1183-1190.
[1] Baker JF, Krishnan E, Chen L,et al. Serum uric acid and cardiovascular disease:recent developments, where do they leave us?, Am J Med 118,2005:816-826.
[2] Wannamethee SGSerum uric acid and risk of coronary heart disease, Curr Pharm Des 11 ,2005:4125-4132.
[3] YuJun-wen, LuJin-bo, ZhangXiao-jusn, et al.The analysis of 1320 elder's blood uric acid and blood-lipid,blood glucose,hypertension.Chinese Journal of Epidemiology ,2005,26:455-457.
[4] Fang Qi,You Kai,Lin Qi-sui,et al.The investigation of Chinese people's blood uric acid and the relationship between it and blood-lipid.Chinese Journal of Internal Midieine,1983,22:434-438.
[5] Fang Wei-gang,Huang Xiao-ming,wang Yu,etal.The analysis of hyperuriemia among 1,997 people's cases in Beijing area and the related faetors.Chinese Journal of Medieine,2006,86(25): 1764-1768.
[6] Zhang Xue shun,Yu Wen-guang,Yu Li-xia,et al.The epidemiology investigation of hyperuricemia and gout in Shandong province Haiyang city community's resident.Chinese Journal of General Praetitioners,2006,5(4):216-219.
[7] Shao Ji-hong,Mo Bao-qing,Yu Rong-bin, et al.The epidemiology Investigation of hyperuric- emia and gout in Nanjing city conmmunity's public.Chjnese Journal of Disease Control and Prevention,2003,7(4):305-308.
[8] OyamaC,Takallashi T,Oyamad,M,et al.Serum Uric acid as an Obesity-Related Indicator in early adolescence.Tohoku J ExP Med,2006,209(3):257-562.
[9] Yu Zhi-min,Zhang Li-song,YangLi-fang.The investigation and analysis of hyperuricemia in Guangzhou area public.Aeta nutrimenta Sinie, 2004,26(3):201-203.
[10] Mohamed FA,et al. On chronic Bright's disease and its essential symptoms.Lancet. 1879, 1:399-401.
[11] Haig A,et al. On uric acid and arterial tension. British Medical Journal. 1889 1:288-291.
[12]Masuo K,Kawaguchi H,Mikami H,et al.Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation.Hypertension.2003;42:474-480.
[13]Jossa F,Farinaro E,Panico S,et al.Serum uric acid and hypertension the Olivetti heart study Hum Hypertens,1994,8:667-681.
[14]Sundstrom J,Sullivan L D,Agostino R B,et al.Relation of serum uric acid to longitudinal blood pressure tracking and hypertension incidence.Hypertension,2005,45:28-33.
[15]Mazzali M,Hughes J,Kim YG,et al.Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism.Hypertension.2001,38:1101-1106.
[16]Mazzali M,Hughes J,Kim YG,et al.Elevated uric increases blood pressure in the rat by anovelcrystla independent mechanism.Hypertension,2001,38(5):1101-1106.
[17]朱宇,纪立农.2型糖尿病患者中高尿酸血症的研究.临床荟萃,2006,21(1):22-24.
[18]鹿斌,董雪红,杨叶虹,等.上海市中心城区成人2型糖尿病患者高尿酸血症患病率及其相关危险因素分析.中国临床医学,2006,13(2):243-245.
[19]Bo S,Cavallo-Perin RGentile L,et al.Hypouricemia and hyperuricemiain type 2diabetes:two different phenotypes.Eur J Clin Invest,2001,31:318-321.
[20]MatsuuraF,Yamhitas,NakamuraT,etal.Efect of visceral fat ccumulation on uric acid metabolism in male obesity subjects visceral fat obesity is linked more closely to over production of uric acid than subcutaneous fatuity.Metaboilsm,1998,47:929-933.
[21]Modan M,Halkin H,Karseik A,et al.Elevated serum uric acid-a fecet of hyperinsulinaemia.Diabetologia,1987,30:713-718.
[22]Matsuura F,Yamashita S,Nakamura T,et al.Effect of visceral fat accumulation on uric acid metabolism in male obese subjects:visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity. Metabolism,1998,47:929-933.
[23]Anker SD,Doehner W,Rauchhaus M,et al.Uric acid and survival in chronic heart failure:validation and application in metabolic,functional,andhemodynamicstaging.Circulation,2003,107(15):1991.
[24]孙丽英,牛秀波,李建博,等.2004年河北省沧州市1215例男性血尿酸、血脂水平分析及痛风发病率的相关调查[J].中国医学检验杂志,2005,6(2):135,157.
[25]余俊文,陆锦波,张小娟,等.1320名老年人血尿酸与血脂、血糖和血压的分析.中华流行病学杂志,2005,26(6):455-457.
[26]Alderman MH.Uric acid and cardiovascular risk.Currop in Phar-macol,2002,2(2):126-130.
[27]Ghei M,M ihaileseu M,Levinson D.Pathogenesis of hyperuricem ia:recent advances.Curr Rheumatol Rep,2002,4(3):270-274.
[28]Chu NF,Wang DJ,L iou SH,et al.Relationship between hyperuricmia and other cardiovascular disease risk factors among adult males in Taiwan.Eur J Ep idem iol,2000,16(1):13-17.
[29]Baker JF,Krishnan E,Chen L,et al.Serum uric acid and cardiovascular disease:recent developments,where do they leave us?,Am J Med 118,2005:816-826
[30]Wannamethee SG.Serum uric acid and risk of coronary heart disease,Curr Pharm Des 11(2005):4125-4132.
[31]CuIleton BF,Larson MG,Kannel WB,et al.Serum uric acid and risk for cardiovascular disease and death:the Framingham heart study.Ann InternMed,1999,131:7-13.
[32]Gertler MM,Gam SM,Levine SA.Serum Uric acid in relation to age and physique in health andin coronary heart disease.Ann Intenr Med,1951,34:1421-1431.
[33]Baker JF,Krishnan E,Chen L.et al.Serum uric acid and cardiovascular disease:Recent developments,and where do they leave us.Am JMed,2005,118(8):816-826.
[34]Niskanen LK,Laaksonen DE,Nyyssonen K,et a.l Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study.Arch InternMed, 2004, 164(14): 1546-1551.
[35] Karagiannis A,Mikhailidis DP,Tziomalos K,et al.Serum uric acid as an independent predictor of early death after acute stroke.Circ J, 2007, 71:1120-1127.
[36] Baker JF,Krishnan E,Chen L. SchumacherHR,et al.Serum uric acid and cardiovasculardisease: Recent developments, and where do they leave us. Am JMed,2005,118(8):816-826.
[37] Suarna C,Dean RT,May J,et al.Human atherosclerotiv piaque contains both oxidized lipids an ascorbate.Arteriolcler Thromb Vasc Biod, 1995,15:1616.
[38] Fang J,Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992.National Health and Nutrition Examination Survey. JAMA, 2000, 283(18): 2404-2410.
[39] Niskanen LK, Laaksonen DE,Nyyssonen K, et a.l Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study.Arch InternMed, 2004, 164(14): 1546-1551.
[40] Kawamoto R,Tomita H,Oka Y,etal.Relationship between serum uric acid concentration,metabolic syndrome and carotid atherosclerosis.Intern Med,2006,45:605-614.
[41] Maxwell SR,Thomason H, Sandier D, et al Antioxidant status in patients with uncomplicated insulin-dependent and noninsulin-dependent diabetes mellitus .Eur JClin Invest ,1997,27:484-490.
[42] Skinner KA,White CR, Patel R, et al Nitrosation of uric acid by peroxynitrite.Formation of avasoactive nitric oxide donor. J BiolChem, 1998,273:24491-24497.
[43] George J,CarrE,Davies J, eta.1High-Dose allopurinol improves endothelial function byprofoundly reducingvascularoxidative stress and not by lowering uric acid[J].Circulation,2006,114(23):2508-2516.
[44] FrohlichM, ImhofA,BergG, eta.I Association betweenC-reactive protein and features of themetabolic syndrome: a population-based study[J]. DiabetesCare, 2000,23:1835-1839.
[45]Shi Y,Evans JE,Rock KL.Molecular identification of a danger signal that alerts the immune system todying cells.Nature,2003,425:516-521.
[46]Ruggiero C,Cherubini A,Ble A,et a.l Uric acid and inflammatory markers.EurHeart J,2006,27(10):1174-1181.
[47]JohnsonRJ,KangDH,FeigD,etal Is there apathogenetic role for uric acid in hypertension and cardiovascularand renaldisease? Hypertension,2003,416:1183-1190.
[48]ErdoganD,GulluH,CaliskanM,eta.l Relationship of serum uric acid to measures of endothelial function and atherosclerosis in healthy adults.International JournalofClinicalPractice,2005,59(11):1276-1282.
[49]Erdogan D,Gullu H,Caliskan M,eta.l Coronary flow reserve and coronary microvascular functionsare strongly related to serum uric acid concentrations in healthy adults.Coron Artery Dis,2006,17(1):7-14.
[50]Hare J,JohnsonR.Uric acid predicts clinical outcomes in heart failure.Insights regarding the role of xanthine oxidase and uric acid in disease pathophysiology,Circulation 107(2003):1951-1953.
[51]Johnson,D.H.Kang,D.Feig,S.et al.Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?Hypertension 41(2003):1183-1190.
[52]邵继红,徐耀初,莫宝庆.高尿酸血症与痛风的分子流行病学研究进展.国外医学卫生学分册,2003,30(4):238-241.
[53]Mann DL,Mechanisms and models in heart failure:A combinational approach.Circulation,1999,100(9):999-1008.
[54]陈章强,洪浪,王洪,等.慢性心力衰竭患者血清尿酸水平的变化及其临床意义.江西医药,2006,41:480-481.
[55]Anker SD,Doehner W,Rauchhaus M,etal.Uric acid and survival in chronic heart failure:validation and application in metabolic,functional,andhemodynamicstaging.Circulation,2003,107:1991-1997.
[56]SingalPK,KhaperN,Palace V,et a.l The role of oxidative stress in the genesis ofheartdisease.CardiolRes,1998,40:426-432.
[57]NianM,Lee P,KhaoerN,et al.Inflammatory cytokines and postmyocardial infarction remodeling.Circ Res,2004,94(12):1543-1553.